Sesen Bio, Inc.

SESN · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$60,477-$19,884-$336-$22,397
Dep. & Amort.$3,354$13$85$122
Deferred Tax$0$0$31,700$0
Stock-Based Comp.$3,649$6,909$5,143$1,757
Change in WC$0$63,006-$48,630$861
Other Non-Cash$0-$25,149-$56,840-$11,180
Operating Cash Flow-$59,917$24,895-$68,878-$30,837
Investing Activities
PP&E Inv.-$123$0-$4-$8
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$128,999$0$0
Inv. Sales/Matur.$0$75,000$0$0
Other Inv. Act.$0$30-$4$0
Investing Cash Flow-$123-$53,969-$4-$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2,392$1$174,962$37,958
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$690$1$176,129$38,113
Financing Cash Flow$344$1$176,129$38,113
Forex Effect$0$0$0$0
Net Chg. in Cash-$59,696-$29,073$107,247$7,268
Supplemental Information
Beg. Cash$77,605$162,656$55,409$48,141
End Cash$17,909$133,583$162,656$55,409
Free Cash Flow-$60,040$24,895-$68,882-$30,845